HomeTERN • NASDAQ
add
Terns Pharmaceuticals Inc
Previous close
$5.79
Day range
$5.74 - $6.03
Year range
$3.68 - $11.40
Market cap
499.44M USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.94M | -24.85% |
Net income | -21.94M | 26.28% |
Net profit margin | — | — |
Earnings per share | -0.28 | 33.33% |
EBITDA | -24.86M | 24.93% |
Effective tax rate | -0.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 372.78M | 39.83% |
Total assets | 378.23M | 39.22% |
Total liabilities | 13.76M | 3.78% |
Total equity | 364.47M | — |
Shares outstanding | 84.94M | — |
Price to book | 1.35 | — |
Return on assets | -20.47% | — |
Return on capital | -21.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -21.94M | 26.28% |
Cash from operations | -16.46M | 20.50% |
Cash from investing | 31.75M | 242.29% |
Cash from financing | 163.29M | 816,360.00% |
Net change in cash | 178.64M | 515.19% |
Free cash flow | -9.58M | 2.19% |
About
Founded
2016
Headquarters
Website
Employees
66
